私たち ニュース Biointron Recognized with 2024 Scientist.com Supplier Performance Recognition Award!

Biointron Recognized with 2024 Scientist.com Supplier Performance Recognition Award!

Biointron 2025-02-07

biointronaward.png

Biointron is proud to share that we have received the 2024 Scientist.com Supplier Performance Recognition Award, for our dedication to providing high-quality drug discovery research services on this industry-renowned R&D sourcing platform. 

The award is based on key performance indicators, including but not limited to: 

  • Responsiveness: the time it takes to respond to client requests 

  • Marketplace activity: the number of requests received/fulfilled 

  • Customer satisfaction: star ratings posted by researchers following completed requests 

With hundreds of orders completed and a 98% response rate, Biointron served researchers from more than 20 top pharmaceutical companies in 2024 on Scientist.com. Additionally, our Antibody Production and Protein Production services are recognized as top services on the platform. 

This recognition reflects the hard work and dedication of the entire Biointron team, as well as the trust and support of our customers. We are honored to have contributed to the success of so many biopharma clients and remain committed to delivering outstanding service and solutions in the year ahead. 

We extend our heartfelt gratitude to Scientist.com and our customers for making this achievement possible! 

Learn more our services > https://www.biointron.com/services/


Subscribe to our ニュース

Recent ニュース

Introducing a new High-throughput Fully Humanized Antibody Discovery Platform with Biointron AbDrop & Cyagen HUGO-Ab! This novel approach combines microfluidic technology for single B cell antibody discovery and fully human antibody mice for a safer and more efficient approach for fully human antibody discovery​, ready in as quickly as 3 months.

Mar 07, 2025
ニュース

In March 2024, Cyagen and Biointron officially signed off on their strategic partnership, forging an alliance in antibody drug development. This partnership aims to fully leverage the strengths of Cyagen's HUGO-Ab™ fully humanized mouse antibody discovery platform and Biointron&#

Mar 23, 2024
ニュース

Biointron is proud to announce a strategic partnership with FatiAbGen, a leading biotechnology firm focused on antibody-based therapeutics. As the newly appointed Korean distributor for Biointron, FatiAbGen will be at the forefront of delivering Biointron’s products to the Korean market.

Mar 15, 2024
ニュース

お客様の利便性を向上させるためにクッキーを使用しています。詳しくは プライバシーポリシー をご覧ください。